rs5911622

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_007325.5(GRIA3):​c.2077-15793T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.52 ( 10650 hom., 16710 hem., cov: 22)
Failed GnomAD Quality Control

Consequence

GRIA3
NM_007325.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.977

Publications

3 publications found
Variant links:
Genes affected
GRIA3 (HGNC:4573): (glutamate ionotropic receptor AMPA type subunit 3) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing at this locus results in different isoforms, which may vary in their signal transduction properties. [provided by RefSeq, Jul 2008]
GRIA3 Gene-Disease associations (from GenCC):
  • syndromic X-linked intellectual disability 94
    Inheritance: XL Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability due to GRIA3 anomalies
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_007325.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007325.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIA3
NM_000828.5
MANE Plus Clinical
c.2077-15793T>C
intron
N/ANP_000819.4P42263-1
GRIA3
NM_007325.5
MANE Select
c.2077-15793T>C
intron
N/ANP_015564.5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIA3
ENST00000620443.2
TSL:1 MANE Select
c.2077-15793T>C
intron
N/AENSP00000478489.1P42263-2
GRIA3
ENST00000622768.5
TSL:5 MANE Plus Clinical
c.2077-15793T>C
intron
N/AENSP00000481554.1P42263-1
GRIA3
ENST00000620581.4
TSL:1
n.2077-15793T>C
intron
N/AENSP00000481875.1A0A087WYJ6

Frequencies

GnomAD3 genomes
AF:
0.520
AC:
57329
AN:
110169
Hom.:
10660
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.510
Gnomad AMI
AF:
0.598
Gnomad AMR
AF:
0.556
Gnomad ASJ
AF:
0.566
Gnomad EAS
AF:
0.413
Gnomad SAS
AF:
0.398
Gnomad FIN
AF:
0.544
Gnomad MID
AF:
0.560
Gnomad NFE
AF:
0.526
Gnomad OTH
AF:
0.531
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.520
AC:
57344
AN:
110226
Hom.:
10650
Cov.:
22
AF XY:
0.514
AC XY:
16710
AN XY:
32540
show subpopulations
African (AFR)
AF:
0.510
AC:
15447
AN:
30270
American (AMR)
AF:
0.556
AC:
5753
AN:
10356
Ashkenazi Jewish (ASJ)
AF:
0.566
AC:
1484
AN:
2622
East Asian (EAS)
AF:
0.413
AC:
1430
AN:
3460
South Asian (SAS)
AF:
0.400
AC:
1034
AN:
2584
European-Finnish (FIN)
AF:
0.544
AC:
3150
AN:
5790
Middle Eastern (MID)
AF:
0.568
AC:
121
AN:
213
European-Non Finnish (NFE)
AF:
0.526
AC:
27733
AN:
52752
Other (OTH)
AF:
0.525
AC:
796
AN:
1517
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1006
2012
3019
4025
5031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
534
1068
1602
2136
2670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.530
Hom.:
79925
Bravo
AF:
0.525

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.52
DANN
Benign
0.73
PhyloP100
-0.98
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs5911622;
hg19: chrX-122582923;
COSMIC: COSV52062156;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.